By Professor Mark Duncan Willcox

Journal articles

Subedi D; Fang T; Bhusal RP; Willcox M, 2023, 'Editorial: Bacteriophages to treat infections with multidrug resistant pathogens', Frontiers in Medicine, 10, http://dx.doi.org/10.3389/fmed.2023.1348463

Kalaiselvan P; Dutta D; Konda NV; Sharma S; Kumar N; Stapleton F; Willcox MDP, 2023, 'Effect of Deposition and Protease Digestion on the Ex Vivo Activity of Antimicrobial Peptide-Coated Contact Lenses', Nanomaterials, 13, pp. 349, http://dx.doi.org/10.3390/nano13020349

Kalaiselvan P; Yasir M; Vijay AK; Willcox MDP; Tummanapalli S, 2023, 'Longevity of hand sanitisers on fingers', Clinical and Experimental Optometry, 106, pp. 436 - 442, http://dx.doi.org/10.1080/08164622.2022.2040334

Sabir S; Das T; Kuppusamy R; Yu TT; Willcox MD; Black DSC; Kumar N, 2023, 'Novel quinazolinone disulfide analogues as pqs quorum sensing inhibitors against Pseudomonas aeruginosa', Bioorganic Chemistry, 130, pp. 106226, http://dx.doi.org/10.1016/j.bioorg.2022.106226

Kuppusamy R; Browne K; Suresh D; Do Rosario RM; Chakraborty S; Yang S; Willcox M; Black D; Chen R; Kumar N, 2023, 'Transition Towards Antibiotic Hybrid Vehicles: The Next Generation Antibacterials', Current Medicinal Chemistry, 30, pp. 104 - 125, http://dx.doi.org/10.2174/0929867329666220613105424

Rayamajhee B; Sharma S; Willcox M; Henriquez FL; Rajagopal RN; Shrestha GS; Subedi D; Bagga B; Carnt N, 2022, 'Assessment of genotypes, endosymbionts and clinical characteristics of Acanthamoeba recovered from ocular infection', BMC Infectious Diseases, 22, pp. 757, http://dx.doi.org/10.1186/s12879-022-07741-4

Aldilla VR; Chen R; Kuppusamy R; Chakraborty S; Willcox MDP; Black DSC; Thordarson P; Martin AD; Kumar N, 2022, 'Hydrogels with intrinsic antibacterial activity prepared from naphthyl anthranilamide (NaA) capped peptide mimics', Scientific Reports, 12, http://dx.doi.org/10.1038/s41598-022-26426-1

Peguda HK; Lakshminarayanan R; Carnt NA; Gu Z; Willcox MDP, 2022, 'The Activity of Polyhomoarginine against Acanthamoeba castellanii', Biology, 11, pp. 1726, http://dx.doi.org/10.3390/biology11121726

Peguda HK; Carnt NA; Gu Z; Kumar N; Willcox MDP; Kuppusamy R, 2022, 'The Anti-Amoebic Activity of a Peptidomimetic against Acanthamoeba castellanii', Microorganisms, 10, pp. 2377, http://dx.doi.org/10.3390/microorganisms10122377

Rayamajhee B; Willcox MDP; Henriquez FL; Petsoglou C; Subedi D; Carnt N, 2022, 'Acanthamoeba, an environmental phagocyte enhancing survival and transmission of human pathogens', Trends in Parasitology, 38, pp. 975 - 990, http://dx.doi.org/10.1016/j.pt.2022.08.007

Konda N; Chakrabarti S; Garg P; Willcox MDP, 2022, 'Association of Single-Nucleotide Polymorphisms in Interleukin Genes with Microbial Keratitis in a South Indian Population', Pathogens, 11, pp. 1387, http://dx.doi.org/10.3390/pathogens11111387

Dutta D; Stapleton F; Willcox M, 2022, 'Ocular Surface Infection and Antimicrobials', Antibiotics, 11, pp. 1496, http://dx.doi.org/10.3390/antibiotics11111496

Afzal M; Vijay AK; Stapleton F; Willcox M, 2022, 'The Relationship between Ciprofloxacin Resistance and Genotypic Changes in S. aureus Ocular Isolates', Pathogens, 11, pp. 1354, http://dx.doi.org/10.3390/pathogens11111354

Cometta S; Jones RT; Juárez-Saldivar A; Donose BC; Yasir M; Bock N; Dargaville TR; Bertling K; Brünig M; Rakić AD; Willcox M; Hutmacher DW, 2022, 'Melimine-Modified 3D-Printed Polycaprolactone Scaffolds for the Prevention of Biofilm-Related Biomaterial Infections', ACS Nano, 16, pp. 16497 - 16512, http://dx.doi.org/10.1021/acsnano.2c05812

Yasir M; Kumar Vijay A; Willcox M; Vijay A, 2022, 'Antiviral effect of multipurpose contact lens disinfecting solutions against coronavirus', Contact Lens and Anterior Eye, 45, pp. 101513, http://dx.doi.org/10.1016/j.clae.2021.101513

Khosravanihaghighi A; Koshy P; Yasir M; Romanazzo S; Lovric V; Kilian KA; Willcox MD; Walsh WR; Sorrell CC, 2022, 'Production of Antibacterial Activity and Bone Cell Proliferation by Surface Engineering of Ga- or Mn-Doped Ceria-Coated Biomedical Titanium Alloy', Advanced Engineering Materials, 24, http://dx.doi.org/10.1002/adem.202200077

Khan M; McDonald M; Mundada K; Willcox M, 2022, 'Efficacy of Ultraviolet Radiations against Coronavirus, Bacteria, Fungi, Fungal Spores and Biofilm', Hygiene, 2, pp. 120 - 131, http://dx.doi.org/10.3390/hygiene2030010

Alenezi H; Ozkan J; Willcox M; Parnell G; Carnt N, 2022, 'Differential gene expression of the healthy conjunctiva during the day', Contact Lens and Anterior Eye, 45, http://dx.doi.org/10.1016/j.clae.2021.101494

Afzal M; Vijay AK; Stapleton F; Willcox MDP, 2022, 'Genomics of Staphylococcus aureus Strains Isolated from Infectious and Non-Infectious Ocular Conditions', Antibiotics, 11, pp. 1011, http://dx.doi.org/10.3390/antibiotics11081011

Bahatheg G; Kuppusamy R; Yasir M; Black DSC; Willcox M; Kumar N, 2022, 'Short Tryptamine-Based Peptoids as Potential Therapeutics for Microbial Keratitis: Structure-Function Correlation Studies', Antibiotics, 11, pp. 1074, http://dx.doi.org/10.3390/antibiotics11081074

Shahzad S; Willcox M, 2022, 'The Possible Role of Prion-Like Viral Protein Domains on the Emergence of Novel Viruses as SARS-CoV-2', Journal of Molecular Evolution, 90, pp. 227 - 230, http://dx.doi.org/10.1007/s00239-022-10054-4

Ozkan J; Willcox M; Coroneo M, 2022, 'A comparative analysis of the cephalic microbiome: The ocular, aural, nasal/nasopharyngeal, oral and facial dermal niches', Experimental Eye Research, 220, pp. 109130, http://dx.doi.org/10.1016/j.exer.2022.109130

Mohid SA; Sharma P; Alghalayini A; Saini T; Datta D; Willcox MDP; Ali H; Raha S; Singha A; Lee DK; Sahoo N; Cranfield CG; Roy S; Bhunia A, 2022, 'A rationally designed synthetic antimicrobial peptide against Pseudomonas-associated corneal keratitis: Structure-function correlation', Biophysical Chemistry, 286, http://dx.doi.org/10.1016/j.bpc.2022.106802

Afzal M; Vijay AK; Stapleton F; Willcox M, 2022, 'Virulence Genes of Staphylococcus aureus Associated With Keratitis, Conjunctivitis, and Contact Lens–Associated Inflammation', Translational Vision Science and Technology, 11, pp. 5, http://dx.doi.org/10.1167/tvst.11.7.5

Sarwat S; Stapleton FJ; Willcox MDP; O’mara PB; Tilley RD; Gooding JJ; Roy M, 2022, 'Feasibility of Silicon Quantum Dots as a Biomarker for the Bioimaging of Tear Film', Nanomaterials, 12, pp. 1965, http://dx.doi.org/10.3390/nano12121965

Wu J; Yu TT; Kuppusamy R; Hassan MM; Alghalayini A; Cranfield CG; Willcox MDP; Black DS; Kumar N, 2022, 'Cholic Acid-Based Antimicrobial Peptide Mimics as Antibacterial Agents', International Journal of Molecular Sciences, 23, pp. 4623, http://dx.doi.org/10.3390/ijms23094623

Asiedu K; Markoulli M; Bonini S; Bron AJ; Dogru M; Kwai N; Poynten A; Willcox MDP; Krishnan AV, 2022, 'Tear film and ocular surface neuropeptides: Characteristics, synthesis, signaling and implications for ocular surface and systemic diseases', Experimental Eye Research, 218, http://dx.doi.org/10.1016/j.exer.2022.108973

Efron N; Morgan PB; Nichols JJ; Walsh K; Willcox MD; Wolffsohn JS; Jones LW, 2022, 'All soft contact lenses are not created equal', Contact Lens and Anterior Eye, 45, pp. 101515, http://dx.doi.org/10.1016/j.clae.2021.101515

Vazquez Campos X; Damnjanovic D; Bridge W; Elliot L; Willcox M, 2022, 'Characterisation of Bacteriophage vB_SmaM_Ps15 Infective to Stenotrophomonas maltophilia Clinical Ocular Isolates', Viruses, 14, pp. 709 - 709, http://dx.doi.org/10.3390/v14040709

Maulvi FA; Shetty KH; Desai DT; Shah DO; Willcox MDP, 2022, 'Corrigendum to ‘Recent advances in ophthalmic preparations: Ocular barriers, dosage forms and routes of administration’. [Int. J. Pharm. 608 (2021) 121105] (International Journal of Pharmaceutics (2021) 608, (S037851732100911X), (10.1016/j.ijpharm.2021.121105))', International Journal of Pharmaceutics, 616, http://dx.doi.org/10.1016/j.ijpharm.2022.121583

Kalaiselvan P; Yasir M; Kuppusamy R; Willcox M; Vijay AK, 2022, 'Ability of Essential Oil Vapours to Reduce Numbers of Culturable Aerosolised Coronavirus, Bacteria and Fungi', Antibiotics, 11, pp. 393, http://dx.doi.org/10.3390/antibiotics11030393

Browne K; Kuppusamy R; Chen R; Willcox MDP; Walsh WR; Black DS; Kumar N, 2022, 'Bioinspired Polydopamine Coatings Facilitate Attachment of Antimicrobial Peptidomimetics with Broad-Spectrum Antibacterial Activity', International Journal of Molecular Sciences, 23, pp. 2952, http://dx.doi.org/10.3390/ijms23062952

Maulvi FA; Kanani PA; Jadav HJ; Desai BV; Desai DT; Patel HP; Shetty KH; Shah DO; Willcox MDP, 2022, 'Timolol-eluting graphene oxide laden silicone contact lens: Control release profile with improved critical lens properties', Journal of Drug Delivery Science and Technology, 69, http://dx.doi.org/10.1016/j.jddst.2022.103134

Desai DT; Maulvi FA; Desai AR; Shukla MR; Desai BV; Khadela AD; Shetty KH; Shah DO; Willcox MDP, 2022, 'In vitro and in vivo evaluation of cyclosporine-graphene oxide laden hydrogel contact lenses', International Journal of Pharmaceutics, 613, http://dx.doi.org/10.1016/j.ijpharm.2021.121414

Das T; Sabir S; Chen R; Farrell J; Kriel FH; Whiteley GS; Glasbey TO; Manos J; Willcox MDP; Kumar N, 2022, 'Halogenated Dihydropyrrol-2-One Molecules Inhibit Pyocyanin Biosynthesis by Blocking the Pseudomonas Quinolone Signaling System', Molecules, 27, pp. 1169, http://dx.doi.org/10.3390/molecules27041169

Kalaiselvan P; Dutta D; Bhombal F; Konda N; Vaddavalli PK; Sharma S; Stapleton F; Willcox MDP, 2022, 'Ocular microbiota and lens contamination following Mel4 peptide-coated antimicrobial contact lens (MACL) extended wear', Contact Lens and Anterior Eye, 45, http://dx.doi.org/10.1016/j.clae.2021.02.017

Kalaiselvan P; Dutta D; Konda N; Vaddavalli PK; Sharma S; Stapleton F; Willcox MDP, 2022, 'Biocompatibility and Comfort during Extended Wear of Mel4 Peptide-Coated Antimicrobial Contact Lenses', Antibiotics, 11, pp. 58, http://dx.doi.org/10.3390/antibiotics11010058

Masoudi S; Willcox M, 2022, 'Development of an enzymatic method for the evaluation of protein deposition on contact lenses', Biofouling, 38, pp. 84 - 99, http://dx.doi.org/10.1080/08927014.2021.2019225

Phan MAT; Madigan MC; Stapleton F; Willcox M; Golebiowski B, 2022, 'Human meibomian gland epithelial cell culture models: Current progress, challenges, and future directions', Ocular Surface, 23, pp. 96 - 113, http://dx.doi.org/10.1016/j.jtos.2021.11.012

Kalaiselvan P; Tummanapalli SS; Kumar Vijay A; Bahl P; MacIntyre CR; Willcox MDP, 2022, 'The ability of face masks to reduce transmission of microbes', Clinical and Experimental Optometry, 105, pp. 214 - 221, http://dx.doi.org/10.1080/08164622.2021.1971050

Kalaiselvan P; Kuppusamy R; Kumar N; Willcox M, 2022, 'Antimicrobial activity of RK-7 peptide mimic against Staphylococcus aureus in solution and when immobilised onto contact lenses', Contact Lens and Anterior Eye, 45, pp. 101607 - 101607, http://dx.doi.org/10.1016/j.clae.2022.101607

Wulandari E; Budhisatria R; Soeriyadi AH; Willcox M; Boyer C; Wong EHH, 2021, 'Releasable antimicrobial polymer-silk coatings for combating multidrug-resistant bacteria', Polymer Chemistry, 12, pp. 7038 - 7047, http://dx.doi.org/10.1039/d1py01219c

Maulvi FA; Soni PD; Patel PJ; Desai AR; Desai DT; Shukla MR; Shah SA; Shah DO; Willcox MDP, 2021, 'Controlled bimatoprost release from graphene oxide laden contact lenses: In vitro and in vivo studies', Colloids and Surfaces B: Biointerfaces, 208, pp. 112096, http://dx.doi.org/10.1016/j.colsurfb.2021.112096

Maulvi FA; Desai DT; Shetty KH; Shah DO; Willcox MDP, 2021, 'Advances and challenges in the nanoparticles-laden contact lenses for ocular drug delivery', International Journal of Pharmaceutics, 608, pp. 121090, http://dx.doi.org/10.1016/j.ijpharm.2021.121090

Maulvi FA; Shetty KH; Desai DT; Shah DO; Willcox MDP, 2021, 'Recent advances in ophthalmic preparations: Ocular barriers, dosage forms and routes of administration', International Journal of Pharmaceutics, 608, pp. 121105, http://dx.doi.org/10.1016/j.ijpharm.2021.121105

Li Y; Ariotti N; Aghaei B; Pandzic E; Ganda S; Willcox M; Sanchez-Felix M; Stenzel M, 2021, 'Inhibition of S. aureus Infection of Human Umbilical Vein Endothelial Cells (HUVECs) by Trehalose- and Glucose-Functionalized Gold Nanoparticles', Angewandte Chemie - International Edition, 60, pp. 22652 - 22658, http://dx.doi.org/10.1002/anie.202106544

Li Y; Ariotti N; Aghaei B; Pandzic E; Ganda S; Willcox M; Sanchez‐Felix M; Stenzel M, 2021, 'Inhibition of S. aureus Infection of Human Umbilical Vein Endothelial Cells (HUVECs) by Trehalose‐ and Glucose‐Functionalized Gold Nanoparticles', Angewandte Chemie, 133, pp. 22834 - 22840, http://dx.doi.org/10.1002/ange.202106544

Chakraborty S; Kuppusamy R; Roohani I; Walsh WR; Willcox MDP; Kumar N; Chen R, 2021, 'Antibacterial peptidomimetic and characterization of its efficacy as an antibacterial and biocompatible coating for bioceramic-based bone substitutes', Materials Advances, 2, pp. 6369 - 6379, http://dx.doi.org/10.1039/d1ma00648g

Yasir M; Dutta D; Willcox MDP, 2021, 'Enhancement of antibiofilm activity of ciprofloxacin against staphylococcus aureus by administration of antimicrobial peptides', Antibiotics, 10, pp. 1159, http://dx.doi.org/10.3390/antibiotics10101159

Afzal M; Vijay AK; Stapleton F; Willcox MDP, 2021, 'Susceptibility of ocular staphylococcus aureus to antibiotics and multipurpose disinfecting solutions', Antibiotics, 10, pp. 1203, http://dx.doi.org/10.3390/antibiotics10101203

Back to profile page